In May 2012, the Los Angeles County Department of Public Health's Acute Communicable Disease Control Unit and Environmental Health, Food, and Milk Program investigated an outbreak of shigellosis associated with a private bridge club. This investigation documented the first known transmission of *Shigella sonnei* with decreased susceptibility to azithromycin in the United States.

Cases were defined as an illness clinically compatible with shigellosis in a patient or *S. sonnei* isolated from stool of a person with an epidemiologic link to the bridge club during May 22--26, 2012. Investigators attempted to interview all bridge club workers and members who had visited the bridge club during the week of May 22; they collected stool specimens from workers who handled food and from workers and members with diarrhea who had not already submitted a stool specimen for culture at a health facility. Thirty-nine cases were identified among club members with diarrhea and four among club workers; of the four workers, two, including one who handled food, reported no symptoms. The average age of affected persons was 75.3 years (range: 54--98 years); 55% were female. Among those with symptoms, the duration of illness averaged 5.9 days (range: 1--14 days). Common symptoms included diarrhea in 95% of patients, abdominal cramps in 70%, and fever in 56%. Thirty-one (72%) persons sought medical care, and 10 (23%) were hospitalized. No specific exposures implicated a source for the outbreak.

Among the 43 cases, 14 were culture-confirmed; 10 isolates underwent pulsed-field gel electrophoresis (PFGE), yielding indistinguishable patterns. Four isolates submitted to CDC's National Antimicrobial Resistance Monitoring System (NARMS) displayed resistance to streptomycin, sulfisoxazole, tetracycline, and trimethoprim-sulfamethoxazole. Unlike most *Shigella* isolates tested by NARMS, these isolates also showed elevated azithromycin minimum inhibitory concentrations (MICs) of \>16 *μ*g/mL ([@b1-171]) and harbored a plasmid-encoded macrolide resistance gene, *mphA* ([@b2-171]).

CDC's PulseNet identified two additional isolates indistinguishable from the outbreak PFGE pattern. One was from a man in Pennsylvania aged 23 years who had visited Los Angeles in April, and the other from a man in Hawaii aged 53 years who visited Los Angeles during April and May; both men were hospitalized with diarrhea. Neither case was epidemiologically linked to the bridge club or to each other.

Although sporadic cases of shigellosis caused by *Shigella* strains with increased azithromycin MICs have occurred, this is the first outbreak documented in the United States and might indicate increasing circulation of such strains ([@b1-171]). Illnesses in this outbreak tended to be severe; however, the affected population was much older than the general U.S. population. Clinical management of such illnesses is likely to be complex; although azithromycin currently is recommended for treatment of infections caused by multidrug-resistant *Shigella,* options for alternative treatment among children with such infections primarily include parenteral antimicrobial medications ([@b3-171],[@b4-171]).

Guidelines for azithromycin susceptibility testing and criteria for interpretation of MICs for *Shigella* species have not been published. Clinicians are urged to report azithromycin treatment failure among shigellosis patients to public health authorities and to retain *Shigella* isolates from such cases for further analysis.
